OH
Ole Henrik Bang-andreasen
Life Science Investments at Avant Bio
United Kingdom
Overview
Ole Henrik Bang-Andreasen is currently working as a Life Science Investments professional at Avant Bio, specializing in investments across various stages and sectors within the life sciences industry. With a background in equity research and financial analysis, Ole has leveraged his analytical skills to successfully navigate roles at reputable organizations such as Tower House Partners LLP and ABG Sundal Collier.
Ole Henrik Bang-Andreasen has a diverse career background, transitioning from roles as a professional cyclist and national rowing team athlete to establishing himself in the finance industry, where he has excelled in equity research and investment analysis, ultimately leading to his current position at Avant Bio focusing on life science investments.
Work Experience
Principal
2025 - Current
Life Science Industrials VC / Growth Equity $3-10m ticket size
Investment Analyst
2024 - 2025
Board Member
2025
Board Member
2024
B2B Life Science marketplace for excess consumables and instruments
Board Observer
2025
Co-Founder & Chairman of the Board
2023
>83% of claims in offshore wind are cable related. Claims are predominantly coming from cable fatigue. The patented Portunus Stabilisation System (PSS) stops cyclic cable fatigue and failure. Available 2025. https://www.youtube.com/watch?v=ghpzq4L8Fd8
Advisory Board Member
2022
Owner
2023
Private HoldCo
Investment Analyst
2019 - 2024
Long/Short Analyst Concentrated $950m low net fund Predominantly focused on Life Science Industrials, Medical Technology, and Diagnostics
Professional Cyclist
2021 - 2022
Equity Research Analyst
2018 - 2019
Life Sciences, Diagnostics & Medical Technologies